Hangzhou, China

Xiankui Tan

This inventor holds 1 USPTO granted patent. Top assignees: Hangzhou Convero Co., Ltd., Other. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiankui Tan. Retrieved from https://idiyas.com/inventor/xiankui-tan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 1 
 
Hangzhou Convero Co., Ltd.
 patent
silverMedal1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiankui Tan: Innovator in Therapeutic Compositions

Introduction

Xiankui Tan is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of therapeutic compositions, particularly in the treatment of tumors and cancers. His innovative approach combines nucleic acids and immune cell therapies to enhance the body's immune response against cancer.

Latest Patents

Xiankui Tan holds a patent for "Therapeutic compositions and applications that comprise nucleic acids and adoptively transferred immune cell." This patent describes a therapeutic agent and method for administering the agent to treat tumors and cancers. The therapeutic agent includes a pharmaceutical composition with a nucleic acid encoding a labeling polypeptide and immune cells purified from peripheral blood or tumor tissue. The administration of this composition prompts tumor cells to express antigenic epitope peptides, eliciting an immune response.

Career Highlights

Throughout his career, Xiankui Tan has worked with various organizations, including Hangzhou Convero Co., Ltd. His work has focused on developing innovative therapies that leverage the body's immune system to combat cancer effectively.

Collaborations

Xiankui Tan has collaborated with notable colleagues, including Yafei Hou and Fang Hu. Their combined expertise has contributed to advancements in therapeutic compositions and cancer treatment methodologies.

Conclusion

Xiankui Tan's work in therapeutic compositions represents a significant advancement in cancer treatment. His innovative approaches and collaborations continue to pave the way for new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…